Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;123(1):59-65.
doi: 10.1002/cncy.21490. Epub 2014 Oct 23.

Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou tests

Affiliations

Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou tests

Christopher L Owens et al. Cancer Cytopathol. 2015 Jan.

Abstract

Background: To the authors' knowledge, few studies to date have examined adherence to recommended guidelines for follow-up and outcomes after an unsatisfactory Papanicolaou (Pap) test (UPT) with liquid-based technologies.

Methods: Within 4 US health plans, the median time to follow-up and the percentage of patients with follow-up testing by 120 days was calculated after a UPT. Multivariable analyses evaluated the association between clinical factors and follow-up testing. The authors compared the risk of a diagnosis of cervical intraepithelial neoplasia of type 2 or worse (CIN2+) after a UPT with the risk after a satisfactory Pap test while controlling for study site, test year, and other covariates.

Results: A total of 634,644 Pap tests performed between 2004 and 2010 were included in the current study. Of 1442 UPTs, 53.4% had follow-up testing within 120 days; follow-up differed across the health plans (P<.001) and was found to be higher among patients aged <50 years (57.2% vs 48.8%; P = .01) and those with positive human papillomavirus (HPV) results (84.6% vs 53.9; P <.01). The risk of CIN2+ was similar for patients with both unsatisfactory and satisfactory Pap tests. However, after a UPT, the variables of age <50 years, having no previous history of Pap testing, having a history of a previous abnormal Pap test, and positive HPV status were all found to be risk factors for CIN2+; a positive HPV test was found to be the strongest risk factor for developing CIN2+. A negative HPV test result was protective for a CIN2+ diagnosis.

Conclusions: Various clinical factors associated with the risk of CIN2+ appear to influence the receipt of follow-up after a UPT. HPV test results in patients with UPTs might be used in follow-up strategies; specifically, a negative test result might reduce the urgency for repeat Pap testing.

Keywords: Papanicolaou test; SurePath; ThinPrep; conventional; liquid-based; unsatisfactory.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement: “The authors have no conflicts of interest to disclose”

Figures

Appendix: Figure 1
Appendix: Figure 1
Consort Diagram
Figure 1
Figure 1
Unsatisfactory Pap test due to insufficient squamous cellularity (ThinPrep, 400×)

References

    1. Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):677–686. - PubMed
    1. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005 May 4;97(9):675–683. - PubMed
    1. Pairwuti S. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix. Acta Cytol. 1991 Jan-Feb;35(1):40–46. - PubMed
    1. Paterson ME, Peel KR, Joslin CA. Cervical smear histories of 500 women with invasive cervical cancer in Yorkshire. Br Med J (Clin Res Ed) 1984 Oct 6;289(6449):896–898. - PMC - PubMed
    1. van der Graaf Y, Vooijs GP, Gaillard HL, Go DM. Screening errors in cervical cytologic screening. Acta Cytol. 1987 Jul-Aug;31(4):434–438. - PubMed

Publication types